Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
For full access to this article login to GEN Select now.
Funding Issues Slow Establishing Biobanks
Obstacles Still to Be Overcome, But Promise Remains
- Anyone looking for short-term returns on investments in biobanks is bound to be disappointed. In fact, such returns will not be seen for decades, according to Jan Carlstedt-Duke, Ph.D., dean of research at the Karolinska Institutet (Stockholm). He spoke at the IBM Healthcare and Life Sciences Biobank Summit III, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.